Galapagos exercises copromotion option for filgotinib with collaboration partner Gilead Sciences in eight European countries

Equity lockup and standstill arrangement between the companies to expire on 31ÂDecemberÂ2017 Mechelen Belgium; 14 December 2017; 22.01 CETÂ Galapagos NV Euronext & NASDAQ GLPG announced today the decision to optin on the copromotion of filgotini...